FDA approves Allergan’s hypertension drug Byvalson
The US Food and Drug Administration (FDA) has approved Allergan’s Byvalson (nebivolol and valsartan) 5 mg/ 80 mg tablets for the treatment of hypertension to lower blood pressure.
Click on this link for more information.
